IRF4 and fatty liver disease: Further investigations are needed to determine whether the ablation of IRF4 in skeletal muscle would affect liver metabolism, given that insulin resistance in skeletal muscles has been linked to increased hepatic de novo lipogenesis and hepatic steatosis in the elderly21.